Laurence Watts | Investor Relations |
Mitchell Gold | Chairman & Chief Executive Officer |
Remy Durand | Senior Vice President, Business Development & Corporate Strategy |
Stanford Peng | President & Head, Research and Development |
Paul Rickey | Chief Financial Officer |
Boris Peaker | Cowen |
Mark Breidenbach | Oppenheimer |
Ted Tenthoff | Piper Jaffray |
Good afternoon, ladies and gentlemen. And thank you for joining the Alpine Immune Sciences' Second Quarter 2020 Financial Results and Corporate Update Conference Call. Currently, all participants are in a listen-only mode.
Following management's prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this conference is being recorded today, Tuesday, August 11, 2020.